# Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)

> **NCT00515957** · PHASE1 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- NASOPHARYNGEAL CARCINOMA

## Interventions

- **GENETIC:** genetically modified CTLs in combo with CD45 antibodies

## Key facts

- **NCT ID:** NCT00515957
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-08
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515957, "Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00515957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*